May 03, 2011
Researchers at last month’s AACR conference in Orlando demonstrated that they are intensifying their efforts to identify and validate various types of biomarkers that are detectable in readily accessible bodily fluids
Apr 29, 2011
Videoscopy™, a groundbreaking new videojournal to complement the peer-reviewed monthly publication, Journal of Laparoendoscopic & Advanced Surgical Techniques has been launched by Mary Ann Liebert, Inc., publishers
Apr 21, 2011
The new neuroscience journal, Brain Connectivity, set to become the premier source of cutting-edge basic and clinical research launches with the publication of four compelling articles.
Apr 15, 2011
Despite the Nobel Prize-winning discovery of RNA interference (RNAi) over a decade ago and the billions of dollars spent developing therapeutic applications, delivery issues continue to challenge the field
Apr 07, 2011
New recommendations from the American Thyroid Association (ATA) on outpatient radioiodine (131I) treatment aim to minimize unintended radiation exposure and maximize the safety of patients, their families, and the public
Apr 06, 2011
The successful use and evaluation of therapeutic hypothermia to improve survival and reduce risk of neurological consequences following out-of-hospital heart attacks explored in premier issue of Therapeutic Hypothermia and Temperature Management
Apr 01, 2011
“Intense” just might be the best term to describe the biotech industry’s pursuit of novel biomarkers for new drug discovery and development efforts
Mar 28, 2011
Shingles and PHN, a new, bimonthly open access peer-reviewed journal, will be launched in fall 2011 by Mary Ann Liebert, Inc., publishers
Mar 14, 2011
Adolescents and young adults affected by cancer require targeted care that crosses the boundaries between pediatric and adult oncology, according to several pioneers in the still-developing field of adolescent and young adult oncology
Mar 14, 2011
The first human studies of an oral drug regimen to prevent HIV infection in high-risk individuals yields promising results, but several issues require additional research before oral pre-exposure prophylaxis (PrEP) can be implemented on a large scale